Robotic Hernia Surgery Market

Overview

The global Robotic Hernia Surgery Market was valued at USD 1.5 billion in 2025 and is projected to reach USD 3.2 billion by 2034, growing at a CAGR of 9.1% during the forecast period (2026-2034). The market growth is driven by increasing adoption of minimally invasive procedures, rising demand for faster patient recovery, technological advancements in robotic surgical systems, increasing prevalence of hernia cases. The market is shifting from a single-platform environment dominated by one multi-port robotic system toward a multi-platform, multi-specialty landscape. Government and regulatory activity is directly shaping market development. The U.S. FDA's 510(k) and De Novo pathways have been the primary regulatory gateways used by manufacturers to add hernia-specific indications during 2025-2026, and the FDA's standard 90-day review target for 510(k) submissions is influencing how quickly new entrants, including non-U.S. manufacturers, can bring hernia-cleared robotic platforms to the world's largest robotic surgery market. By region, North America is estimated to have held the largest share of the Robotic Hernia Surgery Market in 2025, supported by the highest concentration of installed robotic systems, the broadest set of FDA-cleared hernia indications, and high procedure volumes in both hospitals and ambulatory surgery centers. Asia-Pacific is projected to be the fastest-growing region during the forecast period, driven by rapid installed-base growth of domestically developed and imported robotic platforms in India, China, Japan and South Korea, alongside rising surgical volumes and government support for advanced medical-device manufacturing across the region.

Market Size & Share

Market Dynamics

KEY MARKET TREND:

Compact, Modular Robotic Platforms Expanding Robotic Hernia Repair into Ambulatory Surgery Centers

• Purpose-built, smaller-footprint robotic systems designed for outpatient settings are being cleared for the highest-volume soft-tissue ambulatory procedures, allowing ambulatory surgery centers that could not previously justify a full-scale robotic program to add robotic-assisted hernia repair to their service lines.
• Manufacturers are prioritizing sterile, table-side consoles, single-use wristed instruments and mobile, easily repositioned carts so that a single system can move between operating rooms and support several soft-tissue specialties rather than being dedicated to one procedure type.
• Hospitals and surgery centers are increasingly favoring modular systems that can switch between robotic and non-robotic (conventional laparoscopic) workflows in the same room, reducing the infrastructure and staffing changes historically required to start a robotic hernia program.
• Distalmotion's DEXTER Robotic Surgery System received U.S. FDA 510(k) clearance for ventral hernia repair in August 2026, supported by data from the Robotic minimAlly invasive Ventral hErNia repair (RAVEN) study, extending the system's U.S. clearances to the four highest-volume soft-tissue ambulatory procedures, including inguinal and ventral hernia repair, which together account for more than three million annual U.S. procedures.

KEY MARKET DRIVER:

Expanding FDA Clearances for Multi-Specialty Robotic Platforms in Hernia Repair is the Key Driver

• A wave of new and expanded U.S. regulatory clearances between December 2025 and August 2026 has, for the first time, given hospitals and surgery centers a genuine choice of FDA-cleared robotic platforms for hernia repair beyond a single incumbent system, intensifying competitive investment in hernia-specific clinical evidence and instrument development.
• Robotic penetration of inguinal hernia repair has risen from below 1% to more than 24% of procedures over roughly six years, and ventral hernia repair robotic penetration has risen from near zero to approximately 17% over the same period, indicating a durable, technology-led shift in surgeon and hospital preference rather than a short-term trend.
• Regulatory support extends beyond the robotic systems themselves to robotic-compatible consumables; expanded 510(k) clearances for meshes and fixation devices engineered specifically for robotic-assisted placement are lowering the practical barriers surgeons face when moving hernia repair from open or laparoscopic technique to a robotic approach.
• Intuitive Surgical's da Vinci Single Port (SP) system received FDA clearance for inguinal hernia repair, cholecystectomy and appendectomy in December 2025, and the company's own 2025 annual filing reported that U.S. da Vinci general surgery procedure growth was driven notably by cholecystectomy, hernia repair, appendectomy and colorectal procedures, with outside-U.S. da Vinci procedure growth of approximately 23% for the year, also driven in part by hernia repair.

KEY MARKET OPPORTUNITY:

Entry of Cost-Efficient, Domestically Manufactured Platforms Expanding Robotic Hernia Repair Access in Emerging Markets

• Lower-capital-cost, modular robotic platforms developed outside the traditional U.S.-Europe manufacturing base are opening robotic hernia repair to hospitals in price-sensitive markets that were previously unable to justify the capital outlay of established multi-port systems.
• Tele-robotic and remote-console surgical models are being clinically evaluated for hernia repair, creating a potential pathway for specialist surgeons to support hernia procedures at hospitals that lack an on-site robotic-trained surgeon, particularly across large geographies with uneven distribution of surgical specialists.
• Government-supported domestic medical-device manufacturing initiatives in several emerging markets are encouraging local production of robotic surgical systems and instruments, which is expected to shorten regulatory and commercial timelines for hernia-specific indications in those markets over the forecast period.
• Government initiatives such as the Production Linked Incentive (PLI) Scheme for Promoting Domestic Manufacturing of Medical Devices support indigenous production, lower dependence on imported medical technologies, and improve affordability of advanced surgical systems.

Robotic Hernia Surgery Market Size, 2025-2034 (USD Billion)

Segmentation Analysis

Analysis by Component

Instruments & Accessories held the largest market share in 2025, because robotic-assisted hernia repair relies on a recurring supply of single-use wristed instruments, trocars, and robotic-compatible mesh and fixation devices for every procedure performed, generating a steady per-case revenue stream that compounds as the installed base of hernia-cleared robotic systems expands. Hospitals and surgery centers replace these instruments and consumables on a per-procedure basis, so this segment's revenue scales directly with hernia procedure volume rather than with capital equipment sales cycles.

Services are projected to grow at the fastest CAGR during the forecast period, supported by rising demand for surgeon training and proctoring programs as multiple new robotic platforms enter hernia repair simultaneously, along with growing adoption of remote monitoring, maintenance contracts and software or AI-assisted guidance features bundled with newer systems. As hospitals operate a wider mix of robotic platforms, demand for structured credentialing and platform-specific training services is expected to rise correspondingly.

Component categories include

               ·           Instruments & Accessories (Dominating Segment)

               ·           Services (Highest CAGR Segment)

               ·           Robotic Systems

               ·           Digital Solutions

Analysis by Hernia Type

Inguinal Hernia held the largest market share in 2025, reflecting its status as the most common hernia type treated surgically worldwide and the hernia type with the longest track record of robotic-assisted repair, with published clinical data showing robotic penetration of inguinal repair rising to more than 24% of procedures in leading markets. Established transabdominal preperitoneal (TAPP) technique, broad surgeon familiarity, and recent FDA clearances for single-port systems in inguinal hernia repair continue to reinforce this segment's leading position.

Ventral & Incisional Hernia is projected to grow at the fastest CAGR during the forecast period, supported by robotic penetration that has risen from near zero to approximately 17% of ventral hernia procedures, newly expanded FDA clearances covering ventral hernia repair on multiple platforms in 2026, and growing use of robotic-compatible self-gripping mesh designed specifically for retromuscular ventral hernia placement.

Hernia Type categories include

               ·           Inguinal Hernia (Dominating Segment)

               ·           Ventral & Incisional Hernia (Highest CAGR Segment)

               ·           Umbilical Hernia

               ·           Hiatal Hernia

Analysis by Surgical Technique

TAPP (Transabdominal Preperitoneal) repair held the largest market share in 2025, as it remains the most widely taught and performed robotic technique for inguinal hernia repair, benefiting from a well-established learning curve, extensive published outcomes data, and compatibility with the majority of multi-port robotic platforms currently cleared for general surgery. Growing robotic surgery volumes and increasing preference for minimally invasive hernia repair are further supporting demand for TAPP procedures.

Single-port robotic techniques are projected to grow at the fastest CAGR during the forecast period, driven by the December 2025 FDA clearance of a single-port robotic platform for inguinal hernia repair and growing surgeon interest in extraperitoneal approaches that avoid entering the peritoneal cavity for both inguinal and ventral hernia repair, reducing the risk of intra-abdominal complications. Increasing clinical experience with single-port systems is expected to further expand their use across specialized hernia centers.

Surgical Technique categories include

               ·           TAPP (Transabdominal Preperitoneal) (Dominating Segment)

               ·           Single-Port Repair (Highest CAGR Segment)

               ·           TEP

               ·           Retromuscular Repair

               ·           Others

Analysis by End User

Hospitals held the largest market share in 2025, supported by the highest concentration of installed multi-port robotic systems, greater capacity to absorb capital equipment costs, and their role in treating more complex ventral and incisional hernia cases that require broader perioperative and critical-care support Increasing investments in robotic-assisted surgical infrastructure are expected to sustain the segment’s leading position during the forecast period.

Ambulatory Surgical Centers are projected to grow at the fastest CAGR during the forecast period, supported by the entry of compact, purpose-built robotic systems specifically cleared for outpatient inguinal and ventral hernia repair, and by clinical feedback indicating that such systems allow surgery centers to treat a meaningfully higher share of hernia patients robotically within existing outpatient scheduling and infrastructure. Shorter procedure times, streamlined patient turnover, and increasing preference for same-day hernia procedures are expected to further support robotic adoption across ambulatory settings.

End User categories include

               ·           Hospitals (Dominating Segment)

               ·           Ambulatory Surgical Centers (Highest CAGR Segment)

               ·           Specialty Hernia Clinics

By Region

Robotic Hernia Surgery Market Regonal Analysis

Robotic Hernia Surgery Market Share 2025, (%)

North America

45%

South America

XX%

Europe

23%

Middle East Africa

XX%

Asia Pacific

23%

Regional Analysis

North America held the largest share of the market in 2025, supported by the United States, where multiple robotic platforms secured hernia-related FDA clearances or authorizations between December 2025 and August 2026, including single-port, modular multi-port, and compact ambulatory-focused systems. High procedure volumes, well-developed hospital and ambulatory surgery center infrastructure, and manufacturer investment in U.S. commercial rollouts, training programs, and proctoring networks continue to reinforce the region’s leading position. Canada is witnessing a gradual increase in robotic general-surgery adoption through teaching-hospital programs, while Mexico is developing robotic surgery capabilities across major private and public hospitals. Europe maintains steady demand, led by Germany, supported by advanced surgical infrastructure and established robotic programs, while the United Kingdom, France, and Italy continue expanding robotic-assisted general surgery adoption. Rest of Europe is also gradually increasing the use of robotic platforms across specialized surgical centers.

Asia-Pacific is projected to grow at the fastest CAGR during the forecast period, supported by India’s rapidly expanding domestically manufactured robotic surgery installed base and increasing adoption across major hospitals, including early applications in robotic hernia repair. China is strengthening regional demand through domestic robotic surgical platform development and expanding hospital installations, while Japan and South Korea continue to see steady multi-port robotic general-surgery procedure growth. Rest of Asia-Pacific is witnessing gradual adoption as healthcare facilities invest in advanced surgical technologies. Latin America is supported by Brazil as the largest country market, while Chile is emerging as a faster-growing market alongside increasing robotic surgery adoption across Rest of Latin America. In the Middle East & Africa, Saudi Arabia leads demand through healthcare modernization and advanced surgical investments, while the United Arab Emirates is expanding robotic surgery adoption through technology-focused healthcare facilities, with Rest of Middle East & Africa showing gradual development of robotic-assisted surgical infrastructure.

Countries and Regions Covered

North America (Dominating Region)

o    United States (Largest Country Market)

o    Canada

o    Mexico

Asia-Pacific (Fastest Growing Region)

o    India (Fastest-Growing Country Market)

o    China (Largest Country Market)

o    Japan

o    South Korea

o    Rest of Asia-Pacific

Europe

o    Germany (Largest Country Market)

o    United Kingdom

o    France

o    Italy

o    Rest of Europe

Latin America

o    Brazil (Largest Country Market)

o    Chile (Fastest-Growing Country Market)

o    Rest of Latin America

Middle East & Africa

o    Saudi Arabia (Largest Country Market)

o    United Arab Emirates (Fastest-Growing Country Market)

o    Rest of Middle East & Africa

Market Share

The market is consolidated, with a small number of large medical technology companies such as Intuitive Surgical, Medtronic, Johnson & Johnson MedTech, CMR Surgical, Distalmotion, and SS Innovations holding leading positions through broad regulatory clearances, established training ecosystems and integrated instrument and mesh portfolios, alongside a growing number of specialized challengers including meerecompany, Shanghai MicroPort MedBot, Riverfield, Vicarious Surgical, and LivsMed introducing modular and ambulatory-focused platforms. Between December 2025 and August 2026, several previously dominant single-platform dynamics gave way to genuine multi-platform competition as large incumbents and well-funded specialized entrants each secured hernia-related FDA clearances or authorizations within a compressed period. Key success factors include the breadth of FDA-cleared or CE-marked hernia indications, the depth of robotic-compatible mesh and fixation-device portfolios, surgeon training infrastructure, and the ability to serve both hospital and ambulatory surgery center settings with a single platform. Leading companies are prioritizing expansion of hernia-specific indications, development of robotic-compatible consumables, and partnerships between robotic-platform manufacturers and established mesh and surgical-device makers, alongside continued clinical-study investment to support additional regulatory clearances.

Key Players

           ·           Intuitive Surgical, Inc. (United States)

           ·           Medtronic plc (Ireland)

           ·           Johnson & Johnson MedTech (United States)

           ·           CMR Surgical Ltd (United Kingdom)

           ·           Distalmotion SA (Switzerland)

           ·           KARL STORZ SE & Co. KG (Germany)

           ·           SS Innovations International, Inc. (India)

           ·           meerecompany Inc. (South Korea)

           ·           Shanghai MicroPort MedBot (Group) Co., Ltd. (China)

           ·           Medicaroid Corporation (Japan)

           ·           RIVERFIELD Inc. (Japan)

           ·           Virtual Incision Corporation (United States)

           ·           Vicarious Surgical Inc. (United States)

           ·           LivsMed Inc. (South Korea)

           ·           Stryker Corporation (United States)

Recent Market Developments

• September 2025: North Devon District Hospital in the United Kingdom introduced robotic abdominal wall surgery, using robotic technology for complex ventral hernia repairs and reporting same-day discharge for many patients.
• September 2025: Medtronic reported that its Hugo robotic-assisted surgery system met the safety and effectiveness endpoints in the U.S. Enable Hernia Repair study covering inguinal and ventral hernia procedures.
• February 2026: Medtronic announced the first U.S. surgery using the Hugo robotic system at Cleveland Clinic and stated that hernia repair was among the planned future general-surgery indications.
• July 2026: Johnson & Johnson received FDA De Novo authorization for its OTTAVA Robotic Surgical System, the first table-integrated soft-tissue robotic platform, covering multiple general-surgery procedures including hiatal hernia repair, while a separate U.S. clinical trial of OTTAVA in inguinal hernia procedures continued under an existing investigational device exemption. 

Frequently Asked Questions

Key Questions Answered

Request a Sample

1

What is robotic-assisted hernia repair?

2

What is the CAGR of the Robotic Hernia Surgery Market?

3

Which surgical technique leads the Robotic Hernia Surgery Market?

4

Which hernia type dominates the Robotic Hernia Surgery Market?

5

Which component holds the highest market share?

6

What are the latest FDA clearances in the Robotic Hernia Surgery Market?

7

Who are the end users of robotic hernia surgery systems?

Why Choose IG Transformation

Speak to Analyst

Strong Industry Focus

Extensive Product Offerings

Customer Research Services

Robust Research Methodology

Comprehensive Reports

Latest Technological Developments

Value Chain Analysis

Potential Market Opportunities

Growth Dynamics

Quality Assurance

Post-sales Support

Regular Report Updates